Prophylaxis of migraine: general principles and patient acceptance

References

• AyataCJinHKudoC2006Suppression of cortical spreading depression in migraine prophylaxisAnn Neurol596526116450381
   PubMed Web of Science ®Google Scholar
• BigalMERapoportAMLiptonRB2003Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraineHeadache433364212656704
   PubMed Web of Science ®Google Scholar
• BigalMELiptonRB2006Modifiable risk factors for migraine progression (or for chronic daily headaches) – clinical lessonsHeadache46 Suppl 3S144617034393
   PubMed Web of Science ®Google Scholar
• BlauJN1980Migraine prodromes separated from the aura: Complete migraineBMJ281658607437756
   PubMed Web of Science ®Google Scholar
• BlauJN1984Resolution of migraine attacks: Sleep and the recovery phaseJ Neurol Neurosurg Psychiatry47437426376712
   PubMed Web of Science ®Google Scholar
• BrandesJLSaperJRDiamondMfor the MIGR-002 Study Group2004Topiramate for migraine prevention: a randomized controlled trialJAMA29189657314982912
   PubMed Web of Science ®Google Scholar
• BrandesJLKudrowDBRothrockJF2006Assessing the ability of topiramate to improve the daily activities of patients with migraineMayo Clin Proc81101311917036556
   PubMed Web of Science ®Google Scholar
• DahlofCGHDimenasE1995Migraine patients experience poorer subjective well-being/quality of life even between attacksCephalalgia153167758095
   PubMed Web of Science ®Google Scholar
• DahlofCLoderEDiamondM2007The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trialsHealth Qual Life Outcomes4;515617916258
   PubMed Web of Science ®Google Scholar
• D’AmicoDUsaiSGrazziL2003Quality of life and disability in primary chronic daily headachesNeurol Sci24S97S10012811603
   PubMed Web of Science ®Google Scholar
• D’AmicoDUsaiSGrazziL2004The impact of primary headaches on patients’ lives: Italian experience with the MIDAS and the SF-36 questionnairesHeadache Care11238
   Google Scholar
• D’AmicoDGrazziLUsaiS2005Disability pattern in chronic migraine with medication overuse: a comparison with migraine without auraHeadache455536015953274
   PubMed Web of Science ®Google Scholar
• D’AmicoDLanteri-MinetM2006Migraine preventive therapy: selection of appropriate patients and general principles of managementExpert Rev Neurother611475716893343
   PubMedGoogle Scholar
• D’AmicoDLeoneMGrazziL2008When should “chronic migraine” patients be considered “refractory” to pharmacological prophylaxis?Neurol Sci29Suppl 1S555818545898
   PubMed Web of Science ®Google Scholar
• DaviesGMSantanelloNLiptonRB2000Determinants of patient satisfaction with migraine therapyCephalalgia205546011075838
   PubMed Web of Science ®Google Scholar
• DiamondMLWenzelRGNissanGR2006Optimizing migraine therapy: evidence-based and patient-centered careExpert Rev Neurother6911916784413
   PubMed Web of Science ®Google Scholar
• DiezFIStraubeAZanchinG2007Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptanJ Neurol254242917334957
   PubMed Web of Science ®Google Scholar
• DowsonAJSenderJLipscombeS2003Establishing principles for migraine management in primary careInt J Clin Pract5749350712918889
   PubMed Web of Science ®Google Scholar
• DowsonAJTepperSJBaosV2004Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaireCurrent Med Res Opin20112535
   PubMed Web of Science ®Google Scholar
• DowsonAJTepperSJDahlofC2005Patients’ preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraineJ Headache Pain61122016355291
   PubMedGoogle Scholar
• DiamondSBigalMESilbersteinS2007Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention StudyHeadache473556317371352
   PubMed Web of Science ®Google Scholar
• D’AmicoDSolariAUsaiSfor the Progetto Cefalee Lombardia Group2006Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre studyCephalalgia266919616686908
   PubMed Web of Science ®Google Scholar
• DienerHCTfelt HansenPDahlofCfor the MIGR-003 Study Group2004Topiramate in migraine prophylaxis – results from a placebo-controlled trial with propranolol as an active controlJ Neuro25194350
   PubMed Web of Science ®Google Scholar
• DienerHCAgostiRAllaisGfor the TOPMAT-MIG-303 Investigators Group2007Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trialLancet Neurol610546217988947
   PubMed Web of Science ®Google Scholar
• DuelandANLeiraRBurkeTA2004The impact of migraine on work, family, and leisure among young women – a multinational studyCurr Med Res Opin20159560415462692
   PubMed Web of Science ®Google Scholar
• GoadsbyPJDodickDWFerrariMD2004TRIPSTAR: prioritizing oral triptan treatment attributes in migraine managementActa Neuro Scand11013743
   PubMed Web of Science ®Google Scholar
• GuiteraVMunozPCastilloJ2002Quality of life in chronic daily headache: a study in a general populationNeurology581062511940693
   PubMed Web of Science ®Google Scholar
• Gursoy-OzdemirYQiuJMatsuokaNBolayH2004Cortical spreading depression activates and upregulates MMP-9J Clin Invest11314475515146242
   PubMed Web of Science ®Google Scholar
• Headache Classification Subcommittee of the International Headache Society2004The international classification of headache disorders: 2nd editionCephalalgia24Suppl 11160
   Google Scholar
• HenryPAurayJPGaudinAF2002Prevalence and clinical characteristics of migraine in FranceNeurology59232712136063
   PubMed Web of Science ®Google Scholar
• JoffeHCohenLSSuppesT2006Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorderBiol Psychiatry5910788616448626
   PubMed Web of Science ®Google Scholar
• KatsaravaZSchneeweissSKurthT2004Incidence and predictors for chronicity of headache in patients with episodic migraineNeurology627889015007133
   PubMed Web of Science ®Google Scholar
• KlapperJ1997Divalproex sodium in migraine prophylaxis: a dose-controlled studyCephalalgia17103389137847
   PubMed Web of Science ®Google Scholar
• KolCMDekkerFNevenAK2008Acceptance or rejection of prophylactic medicine in patients with migraine: a cross-sectional studyBr J Gen Pract589810118307853
   PubMed Web of Science ®Google Scholar
• KosinskiMBaylissMSBjornerJB2003A six-item short-form survey for measuring headache impact: the HIT-6Qual Life Res129637414651415
   PubMed Web of Science ®Google Scholar
• LainezMJEversSKingeE2006Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraineCephalalgia262465616472330
   PubMed Web of Science ®Google Scholar
• LaunerLJTerwindtGMFerrariMD1999The prevalence and characteristics of migraine in a population-based cohortNeurology535374210449117
   PubMed Web of Science ®Google Scholar
• LiptonRBStewartWFDiamondS2001Prevalence and burden of migraine in the United States: data from the American Migraine Study IIHeadache416465711554952
   PubMed Web of Science ®Google Scholar
• LiptonRBBigalMEKolodnerK2003The family impact of migraine: population-based studies in the USA and UKCephalalgia234294012807522
   PubMed Web of Science ®Google Scholar
• LiptonRBSherAISteinerTJ2003Patterns of health care utilization for migraine in England and in the United StatesNeurology60441812578925
   PubMed Web of Science ®Google Scholar
• LiptonRBGöbelHEinhäuplKM2004Petasites hybridus root (butterbur) is an effective preventive treatment for migraineNeurology632240415623680
   PubMed Web of Science ®Google Scholar
• LiptonRBBigalMEDiamondM2007AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapyNeurology68343917261680
   PubMed Web of Science ®Google Scholar
• LucasCChaffautCArtazMA2005FRAMIG 2000: medical and therapeutic management of migraine in FranceCephalalgia252677915773824
   PubMed Web of Science ®Google Scholar
• LucasCGéraudGValadeD2006Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based surveyHeadache467152516643573
   PubMed Web of Science ®Google Scholar
• MacGregorE ABrandesJEikermannA2003Migraine Prevalence and Treatment Patterns: The Global Migraine and Zolmitriptan Evaluation SurveyHeadache43192612864754
   PubMed Web of Science ®Google Scholar
• ManzoniCGTorelliP2007The patient–physician relationship in the approach to therapeutic managementNeurol Sci28S130S13317508159
   PubMed Web of Science ®Google Scholar
• MathewNTStubitsENigamMR1982Transformation of migraine into daily headache: analysis of factorsHeadache226687085263
   PubMed Web of Science ®Google Scholar
• MathewNTRapoportASaperJ2001Efficacy of gabapentin in migraine prophylaxisHeadache411192811251695
   PubMed Web of Science ®Google Scholar
• MeleticheDMLoflandJHYoungWB2001Quality-of life differences between patients with episodic and transformed migraineHeadache41573811437893
   PubMed Web of Science ®Google Scholar
• Members of the task forceEversSAfraJFreseA2006EFNS guideline on the drug treatment of migraine – report of an EFNS task forceEur J Neurol135607216796580
   PubMed Web of Science ®Google Scholar
• MonzónMJLáinezMJ1998Quality of life in migraine and chronic daily headache patientsCephalalgia18638439876889
   PubMed Web of Science ®Google Scholar
• OsterhausJTTownsendRJGandekB1994Measuring the functional status and well-being of patients with migraine headacheHeadache34337437928312
   PubMed Web of Science ®Google Scholar
• PeresMFSilbersteinSMoreiraF2007Patients’ preference for migraine preventive therapyHeadache47540517445103
   PubMed Web of Science ®Google Scholar
• PowersCSzetoSPangtayD2000Evaluation of migraineurs’ preferences for naratriptan over conventional first-line agentsArch Fam Med9753810927717
   PubMedGoogle Scholar
• RamadanNMSilbersteinSDFreitagFG2000Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraineNeurology (serial on line) www.neurology.org
   Google Scholar
• RapoportAMauskopADienerHC2006Long-term migraine prevention with topiramate: open-label extension of pivotal trialsHeadache4611516016866719
   PubMed Web of Science ®Google Scholar
• RoncolatoMFabbriLRecchiaG2000An epidemiological study to assess migraine prevalence in a sample of Italian population presenting to their GPsEur Neurol43102610686468
   PubMed Web of Science ®Google Scholar
• RothBL2007Drugs and valvular heart diseaseN Engl J Med3566917202450
   PubMed Web of Science ®Google Scholar
• RozenTD2006Migraine prevention: what patients want from medication and their physicians (a headache specialty clinic perspective)Headache46750316643577
   PubMed Web of Science ®Google Scholar
• SalonenRAshfordEAGibbsM1999Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study GroupInt J Clin PractSuppl1051622
   Google Scholar
• SándorPSAfraJAmbrosiniA2000Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentialsHeadache4030510759900
   PubMed Web of Science ®Google Scholar
• ScherAIStewartWFRicciJA2003Factors associated with the onset and remission of chronic daily headache in a population-based studyPain10681914581114
   PubMed Web of Science ®Google Scholar
• SheftellFDFeleppaMTepperSJ2004Patterns of use of triptans and reasons for switching them in a tertiary care migraine populationHeadache44661815209687
   PubMed Web of Science ®Google Scholar
• SilbersteinSDSilbersteinMM1990New concepts in the pathognesis of headache-Part IIPain Manag333442
   Google Scholar
• SilbersteinSDLiptonRBSliwinskiM1996Classification of daily and near-daily headaches: field trial of revised IHS criteriaNeurology4787158857711
   PubMed Web of Science ®Google Scholar
• SilbersteinSDfor the US Headache Consortium2000Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standars Subcommittee of the American Academy of NeurologyNeurology557546210993991
   PubMed Web of Science ®Google Scholar
• SilbersteinSDGoadsbyPJ2002Migraine: preventive treatmentCephalalgia2249151212230591
   PubMed Web of Science ®Google Scholar
• SilbersteinSDNetoWSchmittJthe MIGR-001 Study Group2004Topiramate in migraine prevention: results of a large controlled trialArch Neurol61490515096395
   PubMed Web of Science ®Google Scholar
• SilbersteinSDDodickDFreitagF2007Pharmacological approaches to managing migraine and associated comorbidities – clinical considerations for monotherapy versus polytherapyHeadache475859917445108
   PubMed Web of Science ®Google Scholar
• SteinerTJScherAIStewartWF2003The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicityCephalalgia235192712950377
   PubMed Web of Science ®Google Scholar
• StewartWFShederALSimonD1994Migraine prevalence. A review of population-based studiesNeurology44Suppl 4S17S238008222
   PubMed Web of Science ®Google Scholar
• StewartWFShechterALiptonRB1994Migraine heterogeneity. Disability, pain intensity, and attack frequency and durationNeurology446 Suppl 4S24338008223
   PubMed Web of Science ®Google Scholar
• StewartWFLiptonRBWhyteJ1999An international study to assess reliability of the Migraine Disability Assessment (MIDAS) scoreNeurology539889410496257
   PubMed Web of Science ®Google Scholar
• TepperSJD’AmicoDBaosV2004Guidelines for prescribing prophylactic medications for migraine: a survey among headache specialists in different countriesHeadache Care126772
   Google Scholar
• TepperSJBigalMRapoportASheftellFAlternative therapies: evidence based evaluation in migraineHeadache Care200635764
   Google Scholar
• TerwindtGMFerrariMDTijhuisM2000The impact of migraine on quality of life in the general populationNeurology55624910980723
   PubMed Web of Science ®Google Scholar
• WangSJ2003Epidemiology of migraine and other types of headache in AsiaCurr Neurol Neurosci Rep3104812583837
   PubMedGoogle Scholar
• Ziad elKRahiACHamdanSA2005Age, dose, and environmental temperature are risk factors for topiramate-related hyperthermiaNeurology6511394016217081
   PubMed Web of Science ®Google Scholar